{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteurs cord : Questions médicales les plus fréquentes",
"headline": "Facteurs cord : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteurs cord : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-17",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteurs cord"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Toxines bactériennes",
"url": "https://questionsmedicales.fr/mesh/D001427",
"about": {
"@type": "MedicalCondition",
"name": "Toxines bactériennes",
"code": {
"@type": "MedicalCode",
"code": "D001427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.946.123"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Facteurs cord",
"alternateName": "Cord Factors",
"code": {
"@type": "MedicalCode",
"code": "D003311",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Qian Wu",
"url": "https://questionsmedicales.fr/author/Qian%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Department of Acupuncture and Moxibustion, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China."
}
},
{
"@type": "Person",
"name": "E Bárbara-Bataller",
"url": "https://questionsmedicales.fr/author/E%20B%C3%A1rbara-Bataller",
"affiliation": {
"@type": "Organization",
"name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain. Electronic address: ebb31604@hotmail.com."
}
},
{
"@type": "Person",
"name": "J L Méndez-Suárez",
"url": "https://questionsmedicales.fr/author/J%20L%20M%C3%A9ndez-Su%C3%A1rez",
"affiliation": {
"@type": "Organization",
"name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain."
}
},
{
"@type": "Person",
"name": "C Alemán-Sánchez",
"url": "https://questionsmedicales.fr/author/C%20Alem%C3%A1n-S%C3%A1nchez",
"affiliation": {
"@type": "Organization",
"name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain."
}
},
{
"@type": "Person",
"name": "P Peñaloza-Polo",
"url": "https://questionsmedicales.fr/author/P%20Pe%C3%B1aloza-Polo",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Roles of long noncoding RNA in triple-negative breast cancer.",
"datePublished": "2023-10-05",
"url": "https://questionsmedicales.fr/article/37795578",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.6600"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA CLAN promotes lymphangiogenesis in the colorectal carcinoma.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36301367",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00428-022-03439-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36528049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cca.2022.12.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.",
"datePublished": "2022-08-30",
"url": "https://questionsmedicales.fr/article/36042115",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02914-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "The crucial roles of long noncoding RNA SNHGs in lung cancer.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36008615",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02909-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Toxines biologiques",
"item": "https://questionsmedicales.fr/mesh/D014118"
},
{
"@type": "ListItem",
"position": 4,
"name": "Toxines bactériennes",
"item": "https://questionsmedicales.fr/mesh/D001427"
},
{
"@type": "ListItem",
"position": 5,
"name": "Facteurs cord",
"item": "https://questionsmedicales.fr/mesh/D003311"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteurs cord - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteurs cord",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteurs cord",
"description": "Comment diagnostiquer une infection par Cord Factors ?\nQuels tests sont utilisés pour détecter les Cord Factors ?\nLes Cord Factors sont-ils visibles sur une radiographie ?\nPeut-on identifier les Cord Factors par PCR ?\nQuels symptômes peuvent indiquer une infection par Cord Factors ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=RNA,+Long+Noncoding&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteurs cord",
"description": "Quels sont les symptômes d'une infection par Cord Factors ?\nLes Cord Factors provoquent-ils des symptômes immédiats ?\nY a-t-il des symptômes spécifiques aux Cord Factors ?\nComment les symptômes évoluent-ils avec les Cord Factors ?\nLes Cord Factors causent-ils des douleurs thoraciques ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=RNA,+Long+Noncoding&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteurs cord",
"description": "Comment prévenir une infection par Cord Factors ?\nLa vaccination est-elle efficace contre les Cord Factors ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir l'infection par Cord Factors ?\nLes tests de dépistage sont-ils importants pour la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=RNA,+Long+Noncoding&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteurs cord",
"description": "Quel est le traitement standard pour une infection par Cord Factors ?\nLes Cord Factors nécessitent-ils un traitement prolongé ?\nY a-t-il des traitements alternatifs pour les Cord Factors ?\nLes Cord Factors sont-ils résistants aux antibiotiques ?\nComment surveiller l'efficacité du traitement des Cord Factors ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=RNA,+Long+Noncoding&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteurs cord",
"description": "Quelles complications peuvent survenir avec les Cord Factors ?\nLes Cord Factors peuvent-ils causer des infections systémiques ?\nComment les complications affectent-elles le traitement ?\nLes complications sont-elles fréquentes avec les Cord Factors ?\nQuelles sont les conséquences à long terme des Cord Factors ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=RNA,+Long+Noncoding&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteurs cord",
"description": "Quels sont les principaux facteurs de risque pour les Cord Factors ?\nLe VIH augmente-t-il le risque d'infection par Cord Factors ?\nLes personnes âgées sont-elles plus à risque ?\nLe voyage dans des zones endommagées augmente-t-il le risque ?\nLe contact avec des personnes infectées est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=RNA,+Long+Noncoding&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Cord Factors ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests microbiologiques et des cultures de Mycobacterium."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les Cord Factors ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de culture et des tests sérologiques peuvent être utilisés pour détecter les Cord Factors."
}
},
{
"@type": "Question",
"name": "Les Cord Factors sont-ils visibles sur une radiographie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les Cord Factors ne sont pas visibles sur une radiographie, mais les effets de l'infection le sont."
}
},
{
"@type": "Question",
"name": "Peut-on identifier les Cord Factors par PCR ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR peut être utilisée pour identifier les gènes associés aux Cord Factors."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une infection par Cord Factors ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux persistante, fièvre, et perte de poids, mais varient selon l'individu."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection par Cord Factors ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, fièvre, sueurs nocturnes et fatigue, souvent liés à la tuberculose."
}
},
{
"@type": "Question",
"name": "Les Cord Factors provoquent-ils des symptômes immédiats ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes peuvent prendre du temps à apparaître après l'infection initiale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux Cord Factors ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes sont généralement ceux de la tuberculose, sans spécificité pour les Cord Factors."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec les Cord Factors ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver avec le temps si l'infection n'est pas traitée."
}
},
{
"@type": "Question",
"name": "Les Cord Factors causent-ils des douleurs thoraciques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs thoraciques peuvent survenir en raison de l'infection pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir une infection par Cord Factors ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut la vaccination BCG et des mesures d'hygiène pour éviter la transmission."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle efficace contre les Cord Factors ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination BCG peut réduire le risque de tuberculose, mais n'est pas toujours efficace."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter le contact avec des personnes infectées sont essentiels."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir l'infection par Cord Factors ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter un masque peut réduire le risque de transmission dans les zones à risque."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils importants pour la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce permet d'identifier et de traiter les infections rapidement."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour une infection par Cord Factors ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut des antibiotiques comme l'isoniazide et la rifampicine."
}
},
{
"@type": "Question",
"name": "Les Cord Factors nécessitent-ils un traitement prolongé ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement peut durer plusieurs mois pour éradiquer complètement l'infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs pour les Cord Factors ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs existent, mais ils doivent être prescrits par un médecin."
}
},
{
"@type": "Question",
"name": "Les Cord Factors sont-ils résistants aux antibiotiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines souches de Mycobacterium peuvent développer une résistance aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement des Cord Factors ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est surveillée par des tests de culture et l'évaluation des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les Cord Factors ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la pneumonie, la pleurésie et la dissémination de l'infection."
}
},
{
"@type": "Question",
"name": "Les Cord Factors peuvent-ils causer des infections systémiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une infection non traitée peut se propager et causer des infections systémiques graves."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles le traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent rendre le traitement plus complexe et prolonger la durée de la thérapie."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes avec les Cord Factors ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont possibles, surtout si l'infection n'est pas traitée rapidement."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences à long terme des Cord Factors ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences peuvent inclure des lésions pulmonaires permanentes et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les Cord Factors ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent l'immunodépression, le tabagisme et la malnutrition."
}
},
{
"@type": "Question",
"name": "Le VIH augmente-t-il le risque d'infection par Cord Factors ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le VIH affaiblit le système immunitaire, augmentant le risque d'infection tuberculeuse."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Le voyage dans des zones endommagées augmente-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à forte prévalence de tuberculose augmente le risque d'infection."
}
},
{
"@type": "Question",
"name": "Le contact avec des personnes infectées est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contact étroit avec des personnes infectées augmente le risque de transmission."
}
}
]
}
]
}
Long noncoding RNAs (lncRNAs) play crucial roles in regulating various hallmarks in cancers. Triple-negative (Estrogen receptor, ER; Human epidermal growth factor receptor 2, HER2; Progesterone recept...
We reviewed the current literature on the roles of lncRNAs in the pathogenesis, therapy resistance, and prognosis of patients with TBNC....
LncRNAs are associated with TNBC pathogenesis, therapy resistance, and prognosis. For example, lncRNAs such as small nucleolar RNA host gene 12 (SNHG12), highly upregulated in liver cancer (HULC) HOX ...
In this review, we outline the functions of various lncRNAs along with their molecular mechanisms involved in the pathogenesis, therapeutic resistance of TBNC. Also, the prognostic implications of lnc...
Metastasis is the main cause of colorectal cancer (CRC)-related death and lymph node plays a vital role in this process. Long noncoding RNAs (lncRNAs) are emerging as an important factor of biological...
Long non-coding RNAs (LncRNAs) are single-stranded RNAs over 200 nucleotides in length that have no protein-coding function and have long been considered non-functional by-products of transcription. R...
Gynecologic cancers are reproductive disorders characterized by pelvic pain and infertility. The identification of new predictive markers and therapeutic targets for the treatment of gynecologic cance...
Lung cancer is one of the most common malignant tumors with growing morbidity and mortality worldwide. Several treatments are used to manage lung cancer, including surgery, radiotherapy and chemothera...
The main pathological change of myocarditis is an inflammatory injury of cardiomyocytes. Long noncoding RNAs (lncRNAs) are closely related to inflammation, and our previous study showed that different...
RNA expression was measured by quantitative reverse-transcription polymerase chain reaction (RT-qPCR). Lipopolysaccharide (LPS) was used to induce inflammation in human cardiomyocytes (HCMs). The expr...
NONHSAT122636.2 was dynamically expressed in patients with myocarditis and negatively correlated with inflammation severity. The overexpression of NONHSAT122636.2 improved inflammatory injury in LPS-s...
NONHSAT122636.2 attenuates myocardial inflammation and apoptosis in myocarditis. Additionally, its expression decreases in the peripheral blood of children suffering from myocarditis and in patients w...
IgA nephropathy (IgAN) is one of the most common primary glomerular diseases worldwide, especially in young Asian adults. Long RNA H19 is associated with renal pathologies, such as renal cell injury; ...
Our cohort consisted of 204 patients with IgAN. Serum H19 levels were determined with reverse-transcription quantitative polymerase between 1 May, 2014 and 1 May, 2015. H19 levels were log-transformed...
H19 expression was significantly downregulated in patients with IgAN compared to healthy controls. Restricted cubic spline analyses showed that the relationship was negatively and linearly correlated ...
H19 is an independent protective factor, and a high level of H19 often indicates better renal outcome within 5 years....
Increasing evidence has demonstrated that high TTN-AS1 expression is highly related to poor prognosis in diverse human cancers. However, the findings concerning the prognostic value of TTN-AS1 were in...
Web of Science, Springer, Embase, PubMed, Cochrane Library, and Scopus databases were comprehensively searched to retrieve studies related to the TTN-AS1 expression with the prognosis of malignancies....
Twenty studies involving 17 different cancers and 1330 patients were recruited into this meta-analysis. The research revealed that high TTN-AS1 expression was remarkably associated with unfavorable ov...
The results of this meta-analysis support that high TTN-AS1 expression significantly correlates with worse prognosis in various cancers. Therefore, TTN-AS1 may be considered as a novel biomarker for m...
Macrophages play an essential role in maintaining the normal function of the innate and adaptive immune responses during host defence. Macrophages acquire diverse functional phenotypes in response to ...
Cancer has become the most common life-threatening disease in the world. Cancers presenting with advanced stages and metastasis show poor prognosis, even with the application of radiotherapy, surgery,...